Skip to main content

Advertisement

SpringerLink
Log in

Melanoma in pregnancy

  • Special Section: Cancer in Pregnancy.
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Melanoma is one of the most common types of cancer diagnosed during pregnancy. Patients with advanced disease require frequent staging examinations (e.g., CT, PET, MRI, ultrasound), which, during pregnancy must be modified from routine protocol to minimize risk to the fetus. We will review the diagnostic and treatment approach to pregnant patients with melanoma, with a discussion and pictorial examples of imaging protocol modifications, and the appearance of metastatic melanoma on radiology exams using modified protocols due to pregnancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Cottreau CM, Dashevsky I, Andrade SE, Li DK, Nekhlyudov L, Raebel MA, Ritzwoller DP, Partridge AH, Pawloski PA, Toh S. Pregnancy-Associated Cancer: A U.S. Population-Based Study. J Womens Health (Larchmt) 2019;28(2):250–257. https://doi.org/10.1089/jwh.2018.6962

  2. Garbe C, Amaral T, Peris K, Hauschild A, Arenberger P, Bastholt L, Bataille V, Del Marmol V, Dreno B, Fargnoli MC, Grob JJ, Holler C, Kaufmann R, Lallas A, Lebbe C, Malvehy J, Middleton M, Moreno-Ramirez D, Pellacani G, Saiag P, Stratigos AJ, Vieira R, Zalaudek I, Eggermont AMM, European Dermatology Forum tEAoD-O, the European Organization for R, Treatment of C. European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics - Update 2019. Eur J Cancer 2020;126:141–158. https://doi.org/10.1016/j.ejca.2019.11.014

  3. Saleh M, Javadi S, Elsherif S, Patnana M, Sagebiel TL, Torres-Cabala C, Mattei J, Bhosale P, Faria SC. Multimodality Imaging and Genetics of Primary Mucosal Melanomas and Response to Treatment. Radiographics 2021;41(7):1954-1972. https://doi.org/10.1148/rg.2021210063

    Article  PubMed  Google Scholar 

  4. Kiuru M, Li Q, Zhu G, Terrell JR, Beroukhim K, Maverakis E, Keegan THM. Melanoma in women of childbearing age and in pregnancy in California, 1994-2015: a population-based cohort study. J Eur Acad Dermatol Venereol 2022;36(11):2025-2035. https://doi.org/10.1111/jdv.18458

    Article  CAS  PubMed  Google Scholar 

  5. Byrom L, Olsen C, Knight L, Khosrotehrani K, Green AC. Increased mortality for pregnancy-associated melanoma: systematic review and meta-analysis. J Eur Acad Dermatol Venereol 2015;29(8):1457-1466. https://doi.org/10.1111/jdv.12972

    Article  CAS  PubMed  Google Scholar 

  6. Still R, Brennecke S. Melanoma in pregnancy. Obstet Med 2017;10(3):107-112. https://doi.org/10.1177/1753495X17695001

    Article  PubMed  PubMed Central  Google Scholar 

  7. Driscoll MS, Grant-Kels JM. Hormones, nevi, and melanoma: an approach to the patient. J Am Acad Dermatol 2007;57(6):919–931; quiz 932–916. https://doi.org/10.1016/j.jaad.2007.08.045

  8. Jhaveri MB, Driscoll MS, Grant-Kels JM. Melanoma in pregnancy. Clin Obstet Gynecol 2011;54(4):537-545. https://doi.org/10.1097/GRF.0b013e318236e18b

    Article  PubMed  Google Scholar 

  9. Garbe C. [Pregnancy, hormone preparations and malignant melanoma]. Hautarzt 1993;44(6):347–352. https://www.ncbi.nlm.nih.gov/pubmed/8335457.

  10. Berciano-Guerrero MA, Guardamagna M, Perez-Ruiz E, Jurado JM, Barragan I, Rueda-Dominguez A. Treatment of Metastatic Melanoma at First Diagnosis: Review of the Literature. Life (Basel) 2022;12(9). https://doi.org/10.3390/life12091302

  11. Smithy JW, Postow MA. Adjuvant checkpoint blockade following complete local therapy for melanoma metastases. Lancet 2022;400(10358):1082-1083. https://doi.org/10.1016/S0140-6736(22)01748-2

    Article  CAS  PubMed  Google Scholar 

  12. Truong TG, Kennedy LB, Patel SP. 25 Years of Adjuvant Therapy in Melanoma: A Perspective on Current Approvals and Insights into Future Directions. Curr Oncol Rep 2022;24(4):533-542. https://doi.org/10.1007/s11912-022-01232-0

    Article  PubMed  Google Scholar 

  13. Wolchok JD, Chiarion-Sileni V, Gonzalez R, Grob JJ, Rutkowski P, Lao CD, Cowey CL, Schadendorf D, Wagstaff J, Dummer R, Ferrucci PF, Smylie M, Butler MO, Hill A, Marquez-Rodas I, Haanen J, Guidoboni M, Maio M, Schoffski P, Carlino MS, Lebbe C, McArthur G, Ascierto PA, Daniels GA, Long GV, Bas T, Ritchings C, Larkin J, Hodi FS. Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma. J Clin Oncol 2022;40(2):127-137. https://doi.org/10.1200/JCO.21.02229

    Article  CAS  PubMed  Google Scholar 

  14. Ma EZ, Terhune JH, Zafari Z, Blackburn KW, Olson JA, Jr., Mullins CD, Hu Y. Treat Now or Treat Later: Comparative Effectiveness of Adjuvant Therapy in Resected Stage IIIA Melanoma. J Am Coll Surg 2022;234(4):521-528. https://doi.org/10.1097/XCS.0000000000000088

    Article  PubMed  Google Scholar 

  15. Carter TJ, George C, Harwood C, Nathan P. Melanoma in pregnancy: Diagnosis and management in early-stage and advanced disease. Eur J Cancer 2022;166:240-253. https://doi.org/10.1016/j.ejca.2022.02.016

    Article  CAS  PubMed  Google Scholar 

  16. Lorenzi E, Simonelli M, Persico P, Dipasquale A, Santoro A. Risks of molecular targeted therapies to fertility and safety during pregnancy: a review of current knowledge and future needs. Expert Opin Drug Saf 2021;20(5):503-521. https://doi.org/10.1080/14740338.2021.1893299

    Article  CAS  PubMed  Google Scholar 

  17. Zhang YH, Sun HX. Immune checkpoint molecules in pregnancy: Focus on regulatory T cells. Eur J Immunol 2020;50(2):160-169. https://doi.org/10.1002/eji.201948382

    Article  CAS  PubMed  Google Scholar 

  18. Zbytek B, Carlson JA, Granese J, Ross J, Mihm MC, Jr., Slominski A. Current concepts of metastasis in melanoma. Expert Rev Dermatol 2008;3(5):569-585. https://doi.org/10.1586/17469872.3.5.569

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Guidroz JA, Scott-Conner CE, Weigel RJ. Management of pregnant women with breast cancer. J Surg Oncol 2011;103(4):337-340. https://doi.org/10.1002/jso.21673

    Article  PubMed  Google Scholar 

  20. Spanheimer PM, Graham MM, Sugg SL, Scott-Conner CE, Weigel RJ. Measurement of uterine radiation exposure from lymphoscintigraphy indicates safety of sentinel lymph node biopsy during pregnancy. Ann Surg Oncol 2009;16(5):1143-1147. https://doi.org/10.1245/s10434-009-0390-z

    Article  PubMed  Google Scholar 

  21. Guitera P, Menzies SW, Coates E, Azzi A, Fernandez-Penas P, Lilleyman A, Badcock C, Schmid H, Watts CG, Collgros H, Liu R, van Kemenade C, Mann GJ, Cust AE. Efficiency of Detecting New Primary Melanoma Among Individuals Treated in a High-risk Clinic for Skin Surveillance. JAMA Dermatol 2021;157(5):521-530. https://doi.org/10.1001/jamadermatol.2020.5651

    Article  PubMed  Google Scholar 

  22. Jha P, Poder L, Glanc P, Patel-Lippmann K, McGettigan M, Moshiri M, Nougaret S, Revzin MV, Javitt MC. Imaging Cancer in Pregnancy. Radiographics 2022;42(5):1494-1513. https://doi.org/10.1148/rg.220005

    Article  PubMed  Google Scholar 

  23. Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, Long GV, Ross MI, Lazar AJ, Faries MB, Kirkwood JM, McArthur GA, Haydu LE, Eggermont AMM, Flaherty KT, Balch CM, Thompson JF, for members of the American Joint Committee on Cancer Melanoma Expert P, the International Melanoma D, Discovery P. Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin 2017;67(6):472–492. https://doi.org/10.3322/caac.21409

  24. Papageorgiou C, Apalla Z, Manoli SM, Lallas K, Vakirlis E, Lallas A. Melanoma: Staging and Follow-Up. Dermatol Pract Concept 2021;11(Suppl 1):e2021162S. https://doi.org/10.5826/dpc.11S1a162S

    Article  PubMed  PubMed Central  Google Scholar 

  25. Pozsgai M, Nemeth K, Olah P, Gyulai R, Lengyel Z. The significance of imaging examinations during follow-up for malignant melanoma. Eur J Dermatol 2021;31(3):357-363. https://doi.org/10.1684/ejd.2021.4054

    Article  PubMed  Google Scholar 

  26. Balasubramanya R, Selvarajan SK, Cox M, Joshi G, Deshmukh S, Mitchell DG, O'Kane P. Imaging of ocular melanoma metastasis. Br J Radiol 2016;89(1065):20160092. https://doi.org/10.1259/bjr.20160092

    Article  PubMed  PubMed Central  Google Scholar 

  27. Czeyda-Pommersheim F, Weinreb J. Use of Intravenous Contrast During Pregnancy and Lactation. Advances in Clinical Radiology 2021;3:23-39. https://doi.org/10.1016/j.yacr.2021.04.005

    Article  Google Scholar 

  28. Ray JG, Vermeulen MJ, Bharatha A, Montanera WJ, Park AL. Association Between MRI Exposure During Pregnancy and Fetal and Childhood Outcomes. JAMA 2016;316(9):952-961. https://doi.org/10.1001/jama.2016.12126

    Article  PubMed  Google Scholar 

  29. Vandecaveye V, Amant F, Lecouvet F, Van Calsteren K, Dresen RC. Imaging modalities in pregnant cancer patients. Int J Gynecol Cancer 2021;31(3):423-431. https://doi.org/10.1136/ijgc-2020-001779

    Article  PubMed  PubMed Central  Google Scholar 

  30. Takalkar AM, Khandelwal A, Lokitz S, Lilien DL, Stabin MG. 18F-FDG PET in pregnancy and fetal radiation dose estimates. J Nucl Med 2011;52(7):1035-1040. https://doi.org/10.2967/jnumed.110.085381

    Article  PubMed  Google Scholar 

  31. Fahey FH, Palmer MR, Strauss KJ, Zimmerman RE, Badawi RD, Treves ST. Dosimetry and adequacy of CT-based attenuation correction for pediatric PET: phantom study. Radiology 2007;243(1):96-104. https://doi.org/10.1148/radiol.2431060696

    Article  PubMed  Google Scholar 

  32. Giammarile F, Alazraki N, Aarsvold JN, Audisio RA, Glass E, Grant SF, Kunikowska J, Leidenius M, Moncayo VM, Uren RF, Oyen WJ, Valdes Olmos RA, Vidal Sicart S. The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer. Eur J Nucl Med Mol Imaging 2013;40(12):1932-1947. https://doi.org/10.1007/s00259-013-2544-2

    Article  CAS  PubMed  Google Scholar 

  33. Hong GS, Chae EJ, Ryu JS, Chae SY, Lee HS, Yoon DH, Suh C. Assessment of naive indolent lymphoma using whole-body diffusion-weighted imaging and T2-weighted MRI: results of a prospective study in 30 patients. Cancer Imaging 2021;21(1):5. https://doi.org/10.1186/s40644-020-00371-6

    Article  PubMed  PubMed Central  Google Scholar 

  34. Littooij AS, Kwee TC, Barber I, Granata C, Vermoolen MA, Enriquez G, Zsiros J, Soh SY, de Keizer B, Beek FJ, Hobbelink MG, Bierings MB, Stoker J, Nievelstein RA. Whole-body MRI for initial staging of paediatric lymphoma: prospective comparison to an FDG-PET/CT-based reference standard. Eur Radiol 2014;24(5):1153-1165. https://doi.org/10.1007/s00330-014-3114-0

    Article  PubMed  Google Scholar 

  35. Morone M, Bali MA, Tunariu N, Messiou C, Blackledge M, Grazioli L, Koh DM. Whole-Body MRI: Current Applications in Oncology. AJR Am J Roentgenol 2017;209(6):W336-W349. https://doi.org/10.2214/AJR.17.17984

    Article  PubMed  Google Scholar 

  36. Premkumar A, Marincola F, Taubenberger J, Chow C, Venzon D, Schwartzentruber D. Metastatic melanoma: correlation of MRI characteristics and histopathology. J Magn Reson Imaging 1996;6(1):190-194. https://doi.org/10.1002/jmri.1880060134

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to acknowledge the Yale Melanoma Registry and its founder and principal investigator, Stephan Ariyan, M.D. M.B.A. for their contributions to this work.

Author information

Authors and Affiliations

  1. Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA

    Ferenc Czeyda-Pommersheim, Jonathan Langdon & Margarita Revzin

  2. Department of Medical Oncology, Yale School of Medicine, New Haven, CT, USA

    Harriet Kluger

  3. Department of Radiology, Mayo Clinic, Scottsdale, AZ, USA

    Christine Menias

  4. Department of Radiology, Mayo Clinic, Rochester, MN, USA

    Wendaline VanBuren

  5. Department of Dermatology, Yale School of Medicine, New Haven, CT, USA

    Jonathan Leventhal

  6. Yale Center for Clinical Investigation, New Haven, CT, USA

    Raymond Baumann Jr.

Authors
  1. Ferenc Czeyda-Pommersheim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Harriet Kluger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jonathan Langdon
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Christine Menias
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Wendaline VanBuren
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jonathan Leventhal
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Raymond Baumann Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Margarita Revzin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ferenc Czeyda-Pommersheim.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Czeyda-Pommersheim, F., Kluger, H., Langdon, J. et al. Melanoma in pregnancy. Abdom Radiol 48, 1740–1751 (2023). https://doi.org/10.1007/s00261-022-03796-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-022-03796-8

Keywords

Search

Navigation